
View larger version (52K):
[in a new window]
|
Fig. 5. Recombinant epilysin associates with the surface of epithelial cells through the hemopexin domain. (A) Schematic presentation of cDNA-constructs coding for wild type epilysin (Epi*), a catalytically inactive mutant (Epi-E/A*), the pro and catalytic domains (Cat*) or the hemopexin domain (Pex*) in the pEF1/V5-His vector generating recombinant proteins with C-terminal V5-tags (denoted with *). (B) Transiently transfected A549 cells were changed to serum free medium 24 hours post transfection. The conditioned media (upper panel) were harvested and total cell lysates (lower panel) prepared after 24 hours. Comparable amounts of polypeptides from the media and cell lysates were immunodetected with antibodies specific for the V5-tag. Upper panel: 58 kDa: pro-form of Epi* and Epi-E/A* (unfilled arrow); 48 kDa: mature form of Epi* and Epi-E/A* (filled arrow); 28 kDa: Pex* (filled arrowhead) and 23 kDa: mature form of Cat* (unfilled arrowhead, encircled). Brackets indicate degradation products of Epi*, Epi-E/A* and Pex*. Lower panel: 62 kDa: prepro-form of Epi* and Epi-E/A* (filled arrow); 32 kDa: pro-form of Cat* (unfilled arrow); n.s.: nonspecific band. Ctrl denotes empty vector-transfected control. (C,D) A549 cells were transiently transfected as indicated and living, non-permeabilized cells were stained with antibodies specific for the V5-tag(*) and MT1-MMP. MT1 denotes wild type MT1-MMP and MT1-E/A an inactive mutant of MT1-MMP.
|